Welcome to
Breckenridge Pharmaceutical, Inc.

 TOWA PHARMACEUTICAL CO.,LTD.

Breckenridge Pharmaceutical, Inc., the U.S. subsidiary of Towa Pharmaceutical (Osaka, Japan), markets and distributes quality, cost-effective generic pharmaceuticals in the United States.  Our products are developed in our affiliated research and development centers, as well as through strategic partnerships nationwide and around the world. With our dedication to customer service, on-time delivery, reliable supply and quality manufacturing, we improve the health and lives of the patients we and our customers serve.

 

 

Latest News

Norepinephrine Bitartrate Injection, USP launch

Aug 20,2021

Breckenridge Pharmaceutical, Inc. Announces Launch of Norepinephrine Bitartrate Injection, USP (generic for Levophed®)

 

Berlin, Connecticut, August 20, 2021

 

Breckenridge Pharmaceutical, Inc. announces today that it has launched Norepinephrine Bitartrate Injection, USP (generic for Levophed®), manufactured by Rafarm S.A.  Breckenridge will market the product in its own label and offer 4 mg/4 mL (1 mg /mL) strength in cartons of 10 vials.  According to industry sales data, Levophed and its generics had annual sales of $65 million during the twelve months ending June 2021. The U.S. Food and Drug Administration previously granted final approval of this product’s Abbreviated New Drug Application. 

 

 

About Breckenridge:

Breckenridge Pharmaceutical, Inc., a subsidiary of Towa Pharmaceutical (Osaka, Japan), partners with manufacturers nationwide and around the world to bring quality, cost-effective generic pharmaceuticals to U.S. patients.  With our dedication to customer service, on-time delivery, reliable supply and quality manufacturing, we improve the health and quality of life of the patients we and our customers serve.

www.bpirx.com

Read More >>

Apixaban Tablets (generic for Eliquis®) Approved

Aug 05,2021

Breckenridge Pharmaceutical, Inc. announces today that the U.S. Food and Drug Administration has granted final approval of its Abbreviated New Drug Application for Apixaban Tablets (generic for Eliquis®). This product was developed by Towa Pharmaceutical Europe, S.L. in its manufacturing facility located in Martorelles, Spain.  According to industry sales data, Eliquis generated annual sales of $14 billion during the twelve months ending May 2021.  Breckenridge has been granted a license under confidential terms permitting Breckenridge to launch generic Apixaban Tablets under its Abbreviated New Drug Application at a later date.

 

About Breckenridge:

Breckenridge Pharmaceutical, Inc., a subsidiary of Towa Pharmaceutical (Osaka, Japan), partners with manufacturers nationwide and around the world to bring quality, cost-effective generic pharmaceuticals to U.S. patients.  With our dedication to customer service, on-time delivery, reliable supply and quality manufacturing, we improve the health and quality of life of the patients we and our customers serve.

www.bpirx.com

Read More >>

Zolpidem Tartrate Extended-Release Tablets, USP (generic for Ambien® CR) launch

Jul 08,2021

Breckenridge Pharmaceutical, Inc. announced today that it has launched Zolpidem Tartrate Extended-Release Tablets, USP (generic for Ambien® CR), manufactured by Centaur Pharmaceuticals Pvt. Ltd.  Breckenridge will market the product in its own label and offer 6.25 mg and 12.5 mg strengths in bottles of 100. According to industry sales data, Ambien CR and its generics had annual sales of $42 million during the twelve months ending May 2021. The U.S. Food and Drug Administration previously granted final approval of this product’s Abbreviated New Drug Application. 

 

 

About Breckenridge:

Breckenridge Pharmaceutical, Inc., a subsidiary of Towa Pharmaceutical (Osaka, Japan), partners with manufacturers nationwide and around the world to bring quality, cost-effective generic pharmaceuticals to U.S. patients.  With our dedication to customer service, on-time delivery, reliable supply and quality manufacturing, we improve the health and quality of life of the patients we and our customers serve.

www.bpirx.com

 

About Centaur:

Centaur Pharmaceuticals is India’s 32nd largest pharmaceutical company by prescriptions. Centaur provides end to end pharmaceutical solutions and is India’s largest manufacturer and exporter of psychotropic API. Centaur exports its finished formulations to over 100 countries. Centaur recently introduced Woxheal, an NCE, for the first time in the world, in India for Diabetic Foot Ulcer.

www.centaurpharma.com

Read More >>

Product Search

All brand names are registered trademarks of their respective owner(s).